About the Company
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AGRX News
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
Agile Therapeutics, Inc. (NASDAQ: AGRX), the commercial-stage women’s healthcare company, posted a 122% increase in ...
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three and nine months ended ...
Agile Therapeutics, Inc. (AGRX) Q3 2023 Earnings Call Transcript
Good morning, and welcome to the Agile Therapeutics Third Quarter 2023 Financial Results Conference Call. Please note, today's event is being recorded. I would now like to turn the conference over ...
Agile Therapeutics: Q3 Earnings Snapshot
PRINCETON, N.J. — PRINCETON, N.J. — Agile Therapeutics Inc. (AGRX) on Thursday reported a loss of $799,000 in its third quarter. On a per-share basis, the Princeton, New Jersey-based company ...
Agile Therapeutics Inc AGRX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript
Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58. Operator: Good morning, and welcome to the Agile Therapeutics Third Quarter 2023 Financial ...
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
AboutAgileTherapeutics,Inc. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to ...
Agile Therapeutics, Inc. (AGRX)
PRINCETON, NJ / ACCESSWIRE / November 22, 2023 / Agile Therapeutics, Inc. (NASDAQ:AGRX), the commercial-stage women's healthcare company, posted a 122% increase in third-quarter revenue year-over ...
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.
Loading the latest forecasts...